Searched for
SEMAGLUTIDE RISKS
GLP-1 users are suing over vision loss: What does the evidence really show?Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...- How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alphaPGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma...
- Motilal Oswal AMC CEO Prateek Agrawal explains why he is avoiding large banks, IT and FMCG stocksMotilal Oswal AMC is favouring high-growth themes including defence, renewables, hospitals, digital businesses and capital markets, while l...
- In 2019, research began with users of anti-diabetes treatment medicines, now study shows side effect could be hair lossDiabetes treatment: The researchers said while the study was a rigorous one, based on high quality data from a large representative cohort,...
- Widening waistline: India's big, fat obesity hotspots may not be just the biggest cities anymoreIndia sees a significant rise in overweight and obese populations recently. Rural areas show a particularly sharp increase in these health ...
- Dr Reddy's shares crash 9% in 2 days; brokerages slash target prices after semaglutide supply disruption. What lies ahead?Dr Reddy's Laboratories shares extended their decline after the company delayed commercial supplies of its semaglutide product due to a qua...
- Torrent Pharma recalls select batches of Semalix injection after Dr. Reddy's noticeTorrent Pharmaceuticals is voluntarily recalling select batches of its Semalix semaglutide injection pens. This action follows a product re...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
- Weight-loss drug craze for Ozempic, Mounjaro surges in India amid safety concernsIn India, appetite for weight-loss drugs is on the rise, with consumers increasingly turning to injectables such as Mounjaro and Ozempic fo...
- A blockbuster unleashed: What happens when a big fat business explodes?India is set to experience a dramatic shift as Ozempic and Wegovy's active ingredient, semaglutide, becomes widely available. Over 40 India...
- Dr Reddy's readies day-1 launch of semaglutide genericDr Reddy's Laboratories is set to launch a generic version of semaglutide in India on March 21. The company plans to offer both oral and in...
- Novo, Emcure to launch weight-loss drug under new brand in IndiaIn June, Novo Nordisk launched Wegovy (semaglutide) injections in five dosing strengths (0.25, 0.5, 1, 1.7 and 2.4 mg). However, the compan...
- Potential US tariff a significant 'unknown' for business, says Dr Reddy's Lab CEODr. Reddy's Laboratories is closely monitoring a potential US tariff on the pharma sector, viewing it as both a risk and opportunity. The c...
- Novo Nordisk aims for heavy sales in India with WegovyThe achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record for prescriptio...
- Popular weight loss & diabetic drugs Ozempic and Wegovy may lead to sudden vision loss: StudyOzempic and Wegovy, used for diabetes and weight loss, show a link to NAION, a rare eye disorder causing blindness. A study found semagluti...
- Beware of weight loss medications; they can make you go blindA recent study conducted by researchers at Massachusetts Eye and Ear hospital has found a significant link between popular weight loss drug...
- Budget Ozempic: Know about this weight loss trend on Tik Tok and its associated risksIn recent years, Ozempic, the winning diabetic drug is very much in demand, taking the world of weight loss by storm. Here's everything to ...
- Novo Nordisk launches anti-diabetes pill semaglutide in IndiaNovo Nordisk, the Danish drug maker on Thursday announced the launch of oral semaglutide in India for treatment of type 2 diabetes.
- The slimming pill may be here: Study finds new 'game changer' drug to fight obesityThe study says this drug can give results that is only possible through weight-loss surgery.
Load More
